Alnylam Pharmaceuticals, Inc. · Biotechnology
ALNYAlnylam Pharmaceuticals, Inc.
No earnings date on file for this stock yet.
Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →
Alnylam Pharmaceuticals earnings preview: what the record says
Across its last 8 reports, ALNY beat the EPS consensus 7 times out of 8 with a figure on file, and the stock moved an average of 8.3% on the first trading day, closing higher 2 of 8 times. That first-day move was larger than the options-implied move in 2 of 8 reports. Measured over five sessions, the average move was 9.2%.
Historically, ALNY has usually stayed inside its implied move. A beat alone has not been enough: ALNY closed higher after only 2 of its 7 EPS beats. NextPick tracks ALNY in its Biotech basket alongside VRTX, REGN, MRNA, BIIB, UTHR, INCY, BNTX and NBIX, whose prints read through to this one.
Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.
ALNY earnings: key questions
How much does ALNY stock move after earnings?
Over its last 8 reports, ALNY moved an average of 8.3% on the first trading day after earnings. The move was larger than the options-implied move in 2 of 8 reports.
Does ALNY usually beat earnings estimates?
ALNY beat the EPS consensus in 7 of its last 8 reports with a surprise on file and missed in 1.